MRI‐Based Score Helps in Assessing the Severity and in Follow‐up of Pediatric Patients With Perianal Crohn Disease
Open Access
- 1 February 2014
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 58 (2) , 252-257
Abstract
Objectives: The radiologic healing of perianal fistulizing Crohn disease (PfCD) lags behind the clinical healing. Contrast-enhanced pelvic magnetic resonance imaging (MRI) is the radiologic study of choice used to diagnose PfCD in children. The aim was to study whether the various MRI-based radiologic parameters and score can help in staging and follow-up of patients with PfCD. Methods: We performed a retrospective chart review of children with PfCD who underwent contrast-enhanced MRI of the pelvis. The demographic profile, clinical status, and laboratory data of the patients at the time of each MRI examination were noted. Based on the clinical status of the patient at the time of MRI examinations, the MRIs were classified into 3 groups: severe disease, mild-to-moderate disease, and asymptomatic. Each MRI examination was reviewed by a radiologist, who was blinded to the clinical status of the patient. Results: Of the radiologic parameters, the number of fistulas, the complexity of fistulas, and the number of abscesses were significantly lower in the asymptomatic group compared with the mild-to-moderate and severe disease groups. The Van Assche MRI-based score was significantly lower in the asymptomatic group compared with the mild-to-moderate disease (P = 0.01) and the severe disease group (P = 0.002). The percentage increase in fistula activity after gadolinium administration was significantly lower in the asymptomatic group compared with the mild-to-moderate disease (P = 0.026) and severe disease (P = 0.019) groups. The MRI-based scores were significantly higher in the MRI examinations performed at diagnosis compared with those that were performed while the patients were receiving the treatment (P = 0.017). Conclusions: The Van Assche MRI score and the percentage increase in fistula activity after gadolinium administration help in assessing the severity perianal Crohn disease. The Van Assche MRI score may be helpful in documenting healing during therapy of perianal Crohn disease.Keywords
This publication has 28 references indexed in Scilit:
- Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn's diseaseClinical Imaging, 2011
- Long-Term Monitoring of Infliximab Therapy for Perianal Fistulizing Crohn's Disease by Using Magnetic Resonance ImagingClinical Gastroenterology and Hepatology, 2011
- Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease - subgroup results from a placebo-controlled studyAlimentary Pharmacology & Therapeutics, 2010
- American gastroenterological association medical position statement: perianal Crohn’s disease1 1Address requests for reprints to: Chair, Clinical Practice Committee, AGA National Office, c/o Membership Department, 4930 Del Ray Avenue, Bethesda, Maryland 20814. Fax: (301) 654-5920.This Medical Position Statement has been developed under the aegis of the c (AGA). It provides preferred approaches to specific medical problems or issues. The statements herein are derived from the data available at the time of their creation and may need to be modified as new information is generated. Unless otherwise stated, these statements are intended for adult patients. The strength of the evidence upon which the statements are based is noted, with prospective, randomized, controlled trials being the strongest. When adequate data are absent, expert consensus may be used and will be identified as such. This document is not to be construed as a standard of care. All decisions regarding the care of a patient should be made by the physician in consideration of all aspects of the patient’s specific medical circumstances.Gastroenterology, 2003
- Crohn's disease: monitoring disease activityAlimentary Pharmacology & Therapeutics, 2003
- Magnetic resonance imaging in early inflammatory arthritis: what is its role?Rheumatology, 2000
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Prospective evaluation of dynamic contrast enhanced magnetic resonance imaging in the evaluation of fistula in anoBritish Journal of Surgery, 1996
- Usual Therapy Improves Perianal Crohn??s Disease as Measured by a New Disease Activity IndexJournal of Clinical Gastroenterology, 1995
- A classification of fistula-in-anoBritish Journal of Surgery, 1976